Filed: 5/15/2023ACC: 0001123292-23-000057
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $279.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$279.12M
Total AUM (reported)
0.00
Total Shares
Allocation by class
SPONSORED ADS$129.14M46.3%
NOTE 7.250% 12/0$58.08M20.8%
NOTE 5.250% 2/1$46.50M16.7%
SHS$16.64M6.0%
NOTE 6.250%11/1$11.11M4.0%
COM$10.23M3.7%
NOTE 4.750% 5/0$7.42M2.7%
Portfolio Concentration
Top 3$233.72M83.7%
4–10$45.40M16.3%
Top 3 weight
83.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 215.59M
Sole
Full voting authority
26.94M
shares
% of voting shares12.5%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
188.64M
shares
% of voting shares87.5%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeNone · 87.5% of voting shares
Institutional Holdings8
Rows:
Amryt Pharma PLC
SOLEShares0.00
TypeSH
Market value$129.14M
46.27%
Sole
8.86M
Shared
0.00
None
0.00
Biora Inc.
SOLEShares0.00
TypePRN
Market value$58.08M
20.81%
Sole
0.00
Shared
0.00
None
103.50M
Omeros Corp
SOLEShares0.00
TypePRN
Market value$46.50M
16.66%
Sole
0.00
Shared
0.00
None
65.14M
RVL PHARMACEUTICALS PLC
SOLEShares0.00
TypeSH
Market value$16.64M
5.96%
Sole
14.60M
Shared
0.00
None
0.00
Omeros Corp
SOLEShares0.00
TypePRN
Market value$11.11M
3.98%
Sole
0.00
Shared
0.00
None
11.01M
Paratek Pharmaceuticals Inc.
SOLEShares0.00
TypePRN
Market value$7.42M
2.66%
Sole
0.00
Shared
0.00
None
9M
PUMA BIOTECHNOLOGY INC
SOLEShares0.00
TypeSH
Market value$5.54M
1.98%
Sole
1.79M
Shared
0.00
None
0.00
Biora Inc.
SOLEShares0.00
TypeSH
Market value$4.69M
1.68%
Sole
1.69M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Amryt Pharma PLCSOLE | Sponsored ADS | 0.00 | SH | $129.14M 46.27% | 8.86M | 0.00 | 0.00 |
Biora Inc.SOLE | Note 7.250% 12/0 | 0.00 | PRN | $58.08M 20.81% | 0.00 | 0.00 | 103.50M |
Omeros CorpSOLE | NOTE 5.250% 2/1 | 0.00 | PRN | $46.50M 16.66% | 0.00 | 0.00 | 65.14M |
RVL PHARMACEUTICALS PLCSOLE | SHS | 0.00 | SH | $16.64M 5.96% | 14.60M | 0.00 | 0.00 |
Omeros CorpSOLE | NOTE 6.250%11/1 | 0.00 | PRN | $11.11M 3.98% | 0.00 | 0.00 | 11.01M |
Paratek Pharmaceuticals Inc.SOLE | NOTE 4.750% 5/0 | 0.00 | PRN | $7.42M 2.66% | 0.00 | 0.00 | 9M |
PUMA BIOTECHNOLOGY INCSOLE | COM | 0.00 | SH | $5.54M 1.98% | 1.79M | 0.00 | 0.00 |
Biora Inc.SOLE | COM | 0.00 | SH | $4.69M 1.68% | 1.69M | 0.00 | 0.00 |